Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients
Condition: COVID-19 Interventions: Biological: allogeneic human dental pulp stem cells (BSH BTC& Utooth BTC); Other: Intravenous saline injection (Placebo) Sponsors: Renmin Hospital of Wuhan University; Beijing SH Bio-Tech Corporation, Beijing (CN); Utooth Biological Technology Co., Ltd. Hubei (CN) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials